Upload Image (Max 20MB per Image)
Netherland-based ProFibrix has announced the completion of patient enrolment in pivotal Phase III trial with Fibrocaps (FINISH-3). The multicentre, randomised, single-blind study enrolled around 718 surgical patients with mild to moderate ...
Tags: Profibrix, Fibrocaps, Medicine